Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹1,538 Cr
up ₹80.3 Cr vs Jul 2021
- Stocks held
- 25
- unchanged
- Top 10 weight
- 65.1%
- of the portfolio in its ten largest
- Cash & debt
- 1.8%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 5
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In August 2021 it disclosed 25 stocks worth ₹1,538 Cr, up ₹80.3 Cr from Jul 2021. Its largest positions were Sun Pharmaceutical Industries Limited (10.5%), Max Healthcare Institute Limited (7.8%), Cipla Limited (7.5%); the ten largest together made up 65.1% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 58.9% of its equity. Cash and debt stood at 1.8%. Compared with Jul 2021 the fund entered 0 new stocks and exited 0.
Against 229 other Sectoral / Thematic funds
Concentration
90%
Top-10 weight is higher than 90% of peers
Breadth
8%
Holds more stocks than 8% of peers
Cash
27%
Holds more cash than 27% of peers
What these mean: concentration · cash
Holdings in August 2021
Download CSVEvery line the fund disclosed, with the change against Jul 2021. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Sun Pharmaceutical Industries Limited | 10.50% | down 0.30 pts | ₹161 Cr | up ₹4.1 Cr | Added |
| Max Healthcare Institute Limited | 7.76% | up 1.46 pts | ₹119 Cr | up ₹27.6 Cr | Added |
| Cipla Limited | 7.50% | down 0.18 pts | ₹115 Cr | up ₹3.4 Cr | Added |
| Apollo Hospitals Enterprise Limited | 6.80% | up 0.97 pts | ₹105 Cr | up ₹19.7 Cr | Added |
| IPCA Laboratories Limited | 6.61% | up 0.91 pts | ₹102 Cr | up ₹18.6 Cr | Added |
| Divi's Laboratories Limited | 5.66% | down <0.01 pts | ₹87 Cr | up ₹4.5 Cr | Added |
| Procter & Gamble Health Limited | 5.61% | up 0.08 pts | ₹86.3 Cr | up ₹5.6 Cr | Added |
| Lupin Limited | 5.35% | down 0.99 pts | ₹82.3 Cr | down ₹10.2 Cr | Trimmed |
| Dr. Reddy's Laboratories Limited | 5.12% | down 0.29 pts | ₹78.8 Cr | down ₹12 L | Held |
| Alkem Laboratories Limited | 4.24% | up 0.26 pts | ₹65.2 Cr | up ₹7.1 Cr | Added |
| Indoco Remedies Limited | 3.51% | up 0.04 pts | ₹53.9 Cr | up ₹3.4 Cr | Added |
| Dr. Lal Path Labs Limited | 3.40% | up 0.25 pts | ₹52.3 Cr | up ₹6.4 Cr | Added |
| Intuitive Surgical Inc | 3.15% | down 0.01 pts | ₹48.5 Cr | up ₹2.3 Cr | Added |
| Torrent Pharmaceuticals Limited | 2.86% | down 0.12 pts | ₹44 Cr | up ₹49 L | Added |
| Globus Medical Inc | 2.62% | down 0.22 pts | ₹40.3 Cr | down ₹1.1 Cr | Trimmed |
| ICICI Lombard General Insurance Company Limited | 2.50% | up 0.06 pts | ₹38.5 Cr | up ₹2.9 Cr | Added |
| Narayana Hrudayalaya Limited | 2.31% | up 0.10 pts | ₹35.6 Cr | up ₹3.3 Cr | Added |
| Abiomed Inc | 2.30% | up 0.06 pts | ₹35.4 Cr | up ₹2.8 Cr | Added |
| Syngene International Limited | 1.94% | down 0.10 pts | ₹29.8 Cr | up ₹12 L | Held |
| Abbott Laboratories | 1.89% | down 0.06 pts | ₹29.1 Cr | up ₹67 L | Added |
| JB Chemicals & Pharmaceuticals Limited | 1.87% | down 0.23 pts | ₹28.8 Cr | down ₹1.9 Cr | Trimmed |
| Cash, TREPS & receivables | 1.80% | down 1.52 pts | ₹27.7 Cr | down ₹20.7 Cr | Trimmed |
| Alembic Pharmaceuticals Limited | 1.33% | up 0.12 pts | ₹20.4 Cr | up ₹2.9 Cr | Added |
| Unichem Laboratories Limited | 1.25% | down 0.25 pts | ₹19.2 Cr | down ₹2.7 Cr | Trimmed |
| Aarti Drugs Limited | 1.22% | down 0.17 pts | ₹18.8 Cr | down ₹1.6 Cr | Trimmed |
| Kovai Medical Center and Hospital Limited | 0.89% | up 0.14 pts | ₹13.7 Cr | up ₹2.8 Cr | Added |
What changed, Jul 2021 to Aug 2021
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Max Healthcare Institute Limitedup ₹27.6 Cr (+1.46% pts)
- Apollo Hospitals Enterprise Limitedup ₹19.7 Cr (+0.97% pts)
- IPCA Laboratories Limitedup ₹18.6 Cr (+0.91% pts)
- Alkem Laboratories Limitedup ₹7.1 Cr (+0.26% pts)
- Dr. Lal Path Labs Limited ₹6.4 Cr (+0.25% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Jul 2021, the weight rose most in Healthcare Services (+2.6 pts), and fell most in Pharmaceuticals & Biotechnology (−1.9 pts) and Pharmaceuticals (−0.4 pts).
- Healthcare Services23.3% → 25.9%+2.6 pts
- Pharmaceuticals & Biotechnology60.8% → 58.9%−1.9 pts
- Pharmaceuticals7.2% → 6.8%−0.4 pts
- Healthcare Equipment & Supplies6.2% → 5.9%−0.3 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Aug 2020 | Feb 2021 | May 2021 | Jul 2021 | Aug 2021 |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 64.7% | 63.9% | 63.3% | 60.8% | 58.9% |
| Healthcare Services | 19.9% | 22.3% | 21.1% | 23.3% | 25.9% |
| Pharmaceuticals | 9.0% | 7.2% | 6.8% | 7.2% | 6.8% |
| Healthcare Equipment & Supplies | 3.6% | 3.3% | 5.9% | 6.2% | 5.9% |
| Insurance | 2.7% | 3.4% | 2.8% | 2.5% | 2.5% |
Allocation in Aug 2021change vs Jul 2021
- Pharmaceuticals & Biotechnology (12)58.9%▼ 1.9 pts
- Healthcare Services (7)25.9%▲ 2.6 pts
- Pharmaceuticals (3)6.8%▼ 0.4 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Aug 2021
1.8%
▼ 1.5 pts vs Jul 2021
- Cash alone
- 1.8%
- cash and net receivables
- A year earlier
- 4.9%
- Aug 2020 · now ▼ 3.1 pts
- Last 12 months
- 1.8% – 8.5%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.